EpiVacCorona

N/A

Report date: 2022/08/29 20:00:24

Base Information

Drug NameEpiVacCorona

Drug Alias NameN/A

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Genetically engineered subunit vaccineVaccines > Biological material > Viral vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryRussian Federation

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

Originator CompaniesFederal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector"

China Registration ClassN/A

Develop Information

Active CompaniesFederal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector"

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

Other Information

ATC CodeJ07BX